Azithromycin in children who get admitted with severe respiratory difficulty in IC
Phase 3
- Conditions
- Health Condition 1: J960- Acute respiratory failure
- Registration Number
- CTRI/2022/09/045942
- Lead Sponsor
- ARAVINDHAN M
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Mechanically ventilated children (1 month - 18 years) of age admitted
with acute respiratory distress syndrome
Exclusion Criteria
1)Children receiving Azithromycin as a part of treatment
2)Known Allergic reaction to Azithromycin
3)Patients with significant jaundice (Direct bilirubin >1.5mg/dl)
4)QT prolongation >450 milli-seconds/ abnormal heart rhythm
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method